Myocardial Infarction Size Reduction With Atorvastatin
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if oral atorvastatin administered just before
percutaneous coronary angioplasty for acute myocardial infarction improves early and late
heart function as compared to placebo.